
-   Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia. OGFRL1 was identified as one of the potential direct targets of miR-17 according to in silico analysis [PMID: 35536524].
-   Synthetic androgen (R1881) represses mRNA of OGFRL1 in a time-dependent manner in human prostate cancer cells [PMID: 30246052].
